Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TLE3 |
| Upstream (Parents) |
|---|
| (<<) IGF1R → TLE3 |
| (<<) MCM7 → TLE3 |
| (<<) EZH2 → TLE3 |
| (<<) PAK1 → TLE3 |
| Downstream (Children) |
|---|
| TLE3 → HTR4 (>>) |
| TLE3 → CAMK2B (>>) |
| TLE3 → CHRNE (>>) |
| TLE3 → FLJ21369 (>>) |
| TLE3 → JAG2 (>>) |
| TLE3 → TMEM59L (>>) |
| TLE3 → CES3 (>>) |
| TLE3 → XRCC1 (>>) |
| TLE3 → GNA14 (>>) |
| TLE3 → CEP164 (>>) |
| TLE3 → ZNF37B (>>) |
| TLE3 → JUND (>>) |
| TLE3 → HDAC5 (>>) |
| TLE3 → TLE1 (>>) |
| TLE3 → WDR60 (>>) |
| TLE3 → KIAA1009 (>>) |
| TLE3 → SLC35A2 (>>) |
